PamGene Raises €10M Million second Round

Den Bosch, Netherlands-based PamGene announced this week that it has raised €10 million ($11.3 million) in a second round of financing that includes €2.5 million from new investor LCF Rothschild Venture Partners of Paris as well as previous investors Alta Partners (San Francisco), GIMV (Belgium), and LSP (Netherlands).

The company said that the investment will support the development and marketing of the company’s PamStation 96 microarray platform, which is slated for launch in the first quarter of 2004.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

The US National Institutes of Health has developed guidelines to gauge whether frail chimpanzees are healthy enough to be moved to a retirement sanctuary.

Osamu Shimomura, who won the 2008 Nobel Prize in Chemistry for his work on green fluorescent protein, has died.

Stat News reports that the head of IBM Watson Health is leaving her post.

In PLOS this week: analytical approach for finding new genetic associations, analysis of Streptococcus pyogenes-infecting viruses, and more.

Oct
25
Sponsored by
Roche

This webinar will detail a comprehensive strategy that a lab has put in place to evaluate  NGS oncology assays for genomic tumor profiling of plasma and tissue samples.